Cita APA

E, M., I, G., J, N., & G, R. (2021). Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study).

Citación estilo Chicago

E, Martínez-Moragón, García-Moguel I, Nuevo J, y Resler G. Real-world Study in Severe Eosinophilic Asthma Patients Refractory to Anti-IL5 Biological Agents Treated With Benralizumab in Spain (ORBE Study). 2021.

Cita MLA

E, Martínez-Moragón, García-Moguel I, Nuevo J, y Resler G. Real-world Study in Severe Eosinophilic Asthma Patients Refractory to Anti-IL5 Biological Agents Treated With Benralizumab in Spain (ORBE Study). 2021.